etf, xly i think we could be a buyer of that one here. >> thank you all for being so gracious and for letting me fill in for melissa i love the show. thank you all for watching "fast money", "mad money" with tim cramer starts right my mission is simple, to make you money i'm here to level the playing field for all investors. there is always a bull market somewhere. i promise to help you find it. "mad money" starts now hey! i'm cramer welcome to "mad money. i'm trying to make you money my job is to entertain you and educate you and teach you something. call me. sometimes there is just too much good news to ignore. and that's how i explained today's rally. dow gaining 183 points

s&p 500 advancing, nasdaq jumping 1.4% one of the most infuriating aspects of the market is that nothing seems to matter except for bonds. bond yields go higher. money managers, well, they just hit and sell they know you can't fight a market and go higher that's what they think, right? that's when the wall street playbook says sell everything. don't even distinguish let's go back to the missions. the playbook has been turned into an algorithm. you get certain inputs like rapidly rising long term rates, lots of funds sell stocks no matter what. they may not be a human involved in the decision. the bigger the fund, the less there is human at the helm that's how defined they are. and what they typically settle is the s&p 500 the entire bundle of 500 stocks usually through what is dcalleda commodity future no major stocks get left out it is the asset class.

the portfolio managers don't pick and choose what they sell they don't say let's sell the s&p 500 futures except for the 40 stocks. they sell everything they don't want to distinguish why? they don't get paid enough to distinguish between got and bad. they regard stocks as commodities. they're like corn or soy, right they pick that basket apart. that is too much work. they don't want the hassle of picking stocks and they're trying to make a bet not against the individual companies but about the class that are equities think about it how often do you hear big money managers come on tv and name the companies they dislike oh, no for the most part, aside from notable exceptions you just share this vague generalities about how stocks in general are overvetted stocks in general are overvalued s&p 500 costs too much there are times when the top down portfolio managers get a little more granular, they talk

about sectors they don't like, the tech andhealth cares the real famous ones, they run so much money. that's why they talk about the averages trying to pick stocks for them it's like kmod continue vestors betting on a particular stalk of wheat. now on down days, like we had last week, or yesterday before the term, the stocks as commodities now really do work when the market gets hammered everything trades together it feels like a waste of time to distinguish among the grains of stock. look at that grain of stock. the that did well. the greater stock is clorox. that was up. what happens when bond yields go down as it did today the stock market finally catches its breath what happens when j. powell comes to capitol hill and forces a hearing and doesn't go on the anti-inflationary war path nothing like breaking rate hikes for inflation and need four or more of them or more he said we're data dependent like the old days.

maybe once we get over covid there could be a cooldown in inflation. thats what happened today. and it made us want to see what is worth, buy, buy, buy. we see the trees through the forest, so to speak. it turns out that while the forest is looking terrible -- there are enough healthy trees that it makes sense to do some buying so let me give you concrete examples of what is going on in the basket as we just trade -- traded it as a unit first is morgan stanley raises stocks for amazon. $4,000 to $4200. there are so many engineers woking at amazon, there are other bets amazon gained a lot of north american retail market share and had a solid holiday season given mt individual retailers didn't have good christmas numbers because of omicron and the flush, it makes sense that amazon must have had a terrific

quarter. now the stock is zooming i have to tell you something, it is about time. this company at $3,307 is still 400 points below the high. second, apple. all right. now we had multiple research notes that indicate april hl a really good holiday season not to mention excellent chinese sales. that data hasn't matters the stock is getting dumps along with everything else to money managers, it as a few colonels and a bush el much corn it mattered today though the stock had a nice bounce. it did, i'd say, i don't want to say it was against what the s&p 500 did. the s&p 500 lit up let's say when the s&p 500 was still doing nothing, it started to go higher it was a colonel of recognition. third, right now j.p. morgan is having a gigantic health care conference they're having tremendous quarters we heard companies saying terrific things.

it hasn't mattered though. even though the health care got dragged down by selling, well this is a huge sector. for really all the stocks to have good things to say and raise numbers, it should not be overlooked it wasn't. that's kind of nuts. but again, they're part of a bushel that wouldn't matter you could have like a whole grain of giant box of grain and you wouldn't see them from adam. how about the talks that nvidia gave last week do you no he who they gave to? they told about what gaming is doing. it's on the web. data centers are going and how fast the selling has been. and indicators, they indicated this quarter might be better than expected. it was completely ignored. it was driving me crazy that no one even seemed to even listen again, a lot of the hedge funds

say they're pieces of corn on a day like today, they're not in control we all know they've been in trouble right? today we learned that 730 max, the numbers for 2021, they were not that bad now they're not a lot better than expected. think about this travel comes back and the airlines needs more capacity, they could see a big uptick in orders there could be much more to it again, no one cared -- this stuff came out when the market was still down and people yawned y? it is part of the s&p. but when the interest rates calm down, boeing went to the floor of course, the tl is always some companies that do disappoint we have seen a bunch of retailers report weaker than expected numbers for december. the most important month of the year but we're also hearing that january usually not important month but been a barn burner for many companies earnings estimates are being lifted for 2022. inve

inven tore ji so lean. anything more granular than that is too micro xop toik matter maybe you don't care that costco had a fabulous month or cvs had better than expected numbers. the managers, people like me who try to distinguish among the companies are a waste of time and wasting their time they see us as small theinkers looking for valuable quarts of noil a 55 gallon drum. but to you and millions, hundreds of millions of people who don't trade stocks like live cattle or soy bean futures, it does matter. it matters it should matter it always will the bottom line, when bonds finally go in the right direction and jay powell is thoughtful, we get a stock picker's market like we had today. you have to be ready for these the stock market that dives by the bond market sword can also prosper from it. david in florida david? >> boo-yah, jim.

>> boo-yah, david. >> caller: so i'm a member of your executive club. i read a lot how much you love chevron. i also want to ask you about exxon. >> well, i don't blame you first, i'm glad you're in the club, david. but getting ready to do some really exciting things including some videos. now it is very difficult to distinguish exxon from chevron they're both great companies exxon is a lot more trouble company. and it's been going on chevron is better growth that's been going on. we own chevron because we like the balance sheet. we like the dividend and the buyback. exxon is troubled on the buyback. let's sayexxon has been bouncy and stretched. and one look at the dividend even up here after this amazing run from chevron, exxon is yielding 4.9% and chevron is yielding 4.1%. even though chevron had this huge move. let's stick with chevron justin in california >> caller: jim greetings from

sunny san diego. >> good to have you. >> caller: here's the situation. i made an absolute bundle by getting in on tesla early. and i'm thinking that right now might be a really good time to diversify. i'm a huge fan of the ev sector and i'm wondering what would be your top five ev companies aside from tesla >> okay. well, i mean what i've been saying just so we're clear is that ev is a very, very clouded field. crowded. there are so many battery companies. so many companies that make this stuff within a battery so many companies that are just kind of out there making metals like mp. so what i simplify things and say own tesla. they're the number one and if you want what's on the car, do what we did in national alerts and buy ford. a very electrified group of fleet coming out next year and will be more and more electrified. the i think that unlike most of the companies that have ev vehicles, there's are going to

sell well. sometimes there is just too much good news to ignore. and that gives you a stock picker's market where we look through the bushel and find what is great to own. "mad money" tonight, health care is taking over the farm. fresh off the company's presentation of the j.p. morgan health care conference i'm going to talk to the ceo of zoletis. and very inexpensive versus where it was not that long ago then after a couple tough weeks for the nasdaq, could today's bounce be a sign of what's to come or is it just a flash in the pan? i'm going off the charts to find out. and data released on one of the phase three treatments i'm getting the latest on the results with the company's top brass. so stay with cramer.

what does a foster kid need from you? to be brave. to show up. for staying connected. the questions they weren't able to ask. show up for the first day of school, the last day at their current address. for the mornings when everything's wrong. for the manicure that makes everything right, for right now. show up, however you can, for the foster kids who need it most— at helpfosterchildren.com

now that so many quality stocks are down big from the highs, you have to be ready to buy in this new environment. there are a lot of losers that deserve to get the boot, a ton of babies got tossed out with the bath water consider zoetis. health care is not just for humans here's a stock that has been a fabulous long term performer $26 eight years ago. it's now up $212 but this thing was $249 a couple weeks ago. so it's been crushed along with so many other high quality growth names even though it's

got real products, real profits. plus if you're worried about a fed mandated slowdown this is a stock you want to own. the big j.p. morgan health care conference is compelling fueled by the humanization of pets we're going to focus on that and rise in demand for meat for emerging market companies. i'm a believer, you no he that don't take it from me. let's talk to kristen peck she's the ceo. hear more about her vision for the future welcome back to "mad money." >> well, thank you for having me, jim. it is great to be back and certainly to be talking about our three favorite topics, pets and meat and human an monthly bonds. thank you for having me. zblflt that's right. before last time i saw you is before the pandemic. i think thinged changed radically in the pet market so to speak what happened to pets since people have been cooped up at home and what they do how much has it impactedzoetis that level of care of pets and the number of pets that have been adopted has really

skyrocketed? >> absolutely. there has been a boom in the pet market and a few things are driving that as you mentioned, more people are adopting more pets more are staying home with our pets we notice every itch and every wimper i think they're really important long standing trend is who's adopting the pets. which is 50% of the pets are now adopted by millennials and gen-z and much more involved in the care of the pets the they do a lot more research. and really we see that as a trend that will continue to drive the companion animal market in years to come. >> now we use zoetis products for our muts i only know them as zoetis because i know you my wife knows them as high quality products how do you distinguish between your products and the others your brand and your company spends a lot mover on r & d and a lot more kinds of diseases than all the other companies combined in your area.

>> it's a great question from the veterinary space, vets know our products. it's the science and innovation we drive you look at the biggest categories for us, we have the only combination triple combination flea, tick, hard worm product in the u.s. with trio you look at derm, you know, in europe our pain medicine are super excited about this i really think we're investing a lot more to your point and giving direct to consumer advertising and the u.s. and markets around the world to build that brand awareness with the pet owner so that they know the value they're gaiting when they invest in our products. >> people who don't have pets might not know, but owning a pet is expensive is there a price point -- remember, it's cash pay. when you come up with prices, you have to be thinking 10 pen afford to do this. >> absolutely. it's a key part of how we look at it. and, you know, we're not, you know, human help it is a stop pay market. so as we're developing products, we have to be sure that we can

really provide innovative product that meets medical need and at a price point that makes sense for the pet owner. we've been able to launch antibodies in the pet space in self pay which people thought we could never do but with our medicines, we have arts rights drugs and we're seeing great uptick. we've been able to bring innovation to the space at pric point that makes sense. >> we started talking about the emerging markets and livestock livestock has gone up in price a lot of what we eat has gone up in price you got a huge business in china. increasing protein demand. can they afford the product there to make it so that they have enough to eat >> yeah. i mean it's really great question you look at emerging markets it's a big growth driver for us at zoetis. what is really interesting is it is more now like the companion

animal and the livestock market. historically, as you mentioned, china, you know, was mostly a livestock market with companion animals. it's about 50/50 in china. as you look at livestock with the outbreak of asf, i remember right before the pandemic, we had lunch. we were discussing that, you know, you really saw, you know, obviously a real devastating impact you saw the growth of companion animal they leave the herd in china, they're investing in biosecure new technologies and they're really investing with our products and they're sure we have the science, invasion and outcomes they need i think as luke at the emerging markets, they're investing in the high quality products that we have in zoetis in livestock and across companion animal as well >> we think that we all learned that we ought tohave it. >> it is the fastest growing species. it is the fastest growing

species. we're the number one company in agriculture. the focus there is in samonoid markets like norway, chile, canada and really we're seeing increasing levels of fish that we can actually now bring products to market it's mostly on a vaccine market. so we see that as a huge growing space and one we're heavily invested in. >> last thing, you have got that on going buy back. the stock is down 12% for a year i have never seen your stock this high from the top so you know this represents great value. >> we did get approval for a share buy back plan at our board meeting we announced back in december we also been growing our dividend we announced a 30% growth there. but we have an incredibly strong balance street strong cash flow and we can be flexible we think about capital allocation, the first focus is investing in our business.

that certainly in r & d as you mentioned, building capacity for the future demand that we've done direct to consumer we can have the cash flow to invest in business development we announced our acquisition last year that we're hoping to close this year. so, you know, we are certainly really focused on capital allocation and growth and we'll be looking, you know, over the coming months to make sure we allocate that and continue to grow the company and provide value to our shareholders. we have beaten the s&p 500 for eight years now. >> your presentation is excellent as i would only expect from you because you are great steward of your company. i want to thank the ceo of zoetis hardly ever get it this cheap. thank you for coming on the show >> thanks so much, jim every time it had a dip, it is absolutely been right to buy this is one of those dips. "mad money" is back after this

♪ ♪ ♪ digital transformation has failed to take off. because it hasn't removed the endless mundane work we all hate. ♪ ♪ ♪

automation can solve that by taking on repetitive tasks for us. unleash your potential. uipath. reboot work. - [announcer] at southern new hampshire university, we're committed to making college more affordable. that's why we're keeping our tuition the same through the year 2022. - [narrator] i knew snhu was the place for me when i saw how affordable it was. - [narrator] find your degree at snhu.edu.

after brutal beat down, bounce backed nicely today we had a lot of bouncing since we peaked in november. this bounce is real. the question is are we looking at a comeback that started and when the markets fall, i like to take my emotions out of the equation it's easier to let the feelings lead you astray when they're seesawing the way the nasdaq is seesawing. that's where the technicals come in people who mention i want you to

see them yourself. so tonight we're going off the charts with the help of a brilliant technician whose word can you find car carolynboroden.academy a month ago she warned us that the tech heavy investment is head for make or break moment. take a look at the nasdaq 100's daily chart, okay? is it from four weeks ago, she told us that the ndx had a poor support between 14.400 and 15.500 she said this index could resume the uptrend. she would have to get a lot more bearish. the down side could be enormous. that is something we preducted with mr. williams not that long ago. the bouncing off the floor but boroden says even when it was rebounding, it never reached

the full upside price target it made a turn for the worse, there. one that she didn't predict. she likes to measure past swings in if the stock. and then run them through the prism of numbers a series of ratios they repeat endlessly. for some reason, look, i'll never be able to explain it. they do show up all over the stock price, too we don't need to know why it works. we just need to know it has surprising amount of predicting power. when she measures duration or decline, she can identify key dates where securities will likely change the trajectory nasdaq 100 ran into a cluster of these cycles in december it peaked on the 28th before rolling over into the new year so what do we do now

yesterday the ndx broke down below the critical support on the intraday basis finished the day above that level. at this point she says we need to look for the next important set of price parameters along with any timing clues that could help us predict when the climate will run the course. even after today's rebound, she thinks the nasdaq 100 is in bad technical shape. until that changes, it could lead to a lot more down side let's look at the next chart this is a zoom out of a little of the daily chart they had seven timing cycles do you between yesterday and thursday now get this in other words, the same method that predicted a possible peak at the end of december, in other words, should go down. also predicted a possible low some time this weekend that's what happened yesterday the ndx opening big before finishing up slightly. then we got nice follow-through today. she thinks there is a real

possibility this tech rebound could have legs. that's really important. but for all we know, that just means it will last as long as the last tech rebound in late december nasdaq 100 swiftly making lows the how about price levels check out the nasdaq 100 daily chart over the last 12 months. she knows the recent breakdown is already getting close in size, here we take a look. we're going to be looking here close in size to some of the previous declines. so there we got the declines you can see the declines have been very severe when they happen this is symmetry big moves often repeat themselves in a rational stock market that, almost never happens you don't think the symmetry lines based on the scale of the power declines raise the nasdaq 100 could have a new floor of support between 15,000 and 15,162 there is the floor we bottomed yesterday before rebounding 450 points to the

low. as long as that floor support holds, she thinks you're going to view this move at least as a tradable bounce. of that's important. a lot of people feel like okay, we just had everything she is saying, no, it could be tradable it could be more than this however, even if the nasdaq 100 is rebounding off the floor support, you shouldn't assume that it will resume the long term up trend and cruise to all time highs that is the green line fell there and that is the kiss of death for most charts. and there are a lot of manage money managers that follow the charts even if they won't admit it they're selling this bounce today because of that. meanwhile, the favorite buy or sell trigger involves watching the five day moving average and the 13 day moving average. that is one of the most reliable sell signals right now it's very much in effect for the nasdaq 100. five days, blue. 13 days is red

obviously well below it. still, she thinks this could go further. that's what's important for us right now. if there is real follow-through, she might reassess and get more bullish. but you might want to use any additional strength as an opportunity to sell some tech but i would say define that as the unprofitable high price to sales multiple text that have been put through the meat grinder that are giving you dead bounces. if they break down below the support, the down side could be immense. remember, you have to be selective if you want to own tech in this market. they have no patience for the former high flyers that have no plans to furnish a profit in the near future. they were great inflation. they were terrific inflation is under control and the federal reserve is committed to propping up the economy. now that inflation is raging and fed getting ready to tighten, these money losing tech stocks are not very much, well, let's say, they're not where you want to be. instead, i recommend sticking with high quality tech names with great earnings or are profitable with prospect like the ones we own for the

travel trust please tell me you bought into the teeth of the selloff bottom line, the charts by carolyn are tech laden nasdaq 100 was due for a bounce this week and that bounce could continue but don't get too comfortable. don't get too attached to it, she says the overall technical picture remains ugly let's go to chris in new york. chris? >> caller: jim, boo-yah. st. >> boo yashgs chris, what's up >> caller: good luck on sunday i think the eagles have a real chance to win since my jets almost beat tampa bay two weeks ago. >> i agree i think that you take -- i think that we have very little to lose what's going on? >> caller: i was looking for an a shan stock to add to my portfolio except i may have had this one at the wrong time this internet company isn't just that, it's a gaming and electronic payments company. since last october it looks as if the stock has fallen off a

cluf cliff into the sea >> yeah. >> caller: i have three buys into the stock already i want to make sure i'm not catching the fall. my question to you is on se. what are your thoughts >> all right, chris. >> by, hold, or -- >> i would be a buyer. you're in the teeth of another country that just got put on the really bad covid list from our country. i think that country is terrific country and they'll get things under control. don't cut and run from that one. you buy se it's an unfortunate situation. it's like a loss it's like a win from my travel trust. i cannot foresee omicron or delta and se is the same thing hold it and buy more the but don't give up on it. that will be wrong okay, the charts as suggested by carolyn of the nasdaq could go for a bounce back. but she does not think it's going to take out the high so the overall picture remains ugly for her me, i say if you be selective,

you'll be fine much more "mad money" including my exclusive with biomoran could they have treatments for rare diseases and be investors for 2022 you'll check in with the ceo and gambling to streaming, we're in the golden age of content but is it too much content i'm surveying the whole entertainment space and all the calls. so stay with cramer. you're a one-man stitchwork master. but your staffing plan needs to go up a size. you need to hire. i need indeed. indeed you do. indeed instant match instantly delivers quality candidates matching your job description. visit indeed.com/hire

earn about covid-19, matching your job description. the more questions we have. the biggest question now, what's next? what will covid bring in six months, a year? if you're feeling anxious about the future, you're not alone. calhope offers free covid-19 emotional support. call 833-317-4673,

or live chat at calhope.org today. this week we hear all the most exciting biotech stories at that j.p. morgan health care conference long term lagger that's date of birth ready to turn. they have incredibly exciting

news take biomoran. they treat very rare diseases. for the last five years they have not done that much. yesterday they told a story about two products for children with the most common type of disease. it got approved last year. something we heard about a long time ago on the show but could be heren that is a hemophilia treatment that could get approved later this year we had strong data it jumped 5% that doesn't seem kmiz rit with how important the drug s the chairman and ceo of biomarin to get a better sense of where they're headed welcome back to "mad money." >> yes, thank you. thank you, jim sorry i couldn't be there in person wonderful to be with you >> great to see you, sir of i don't think -- maybe because it is zoom maybe because that conference

you weren't thousands of people listening to you but this is an unprecedented set of results that you have for hemophilia this has been one that so many companies have tried and never succeeded. i think -- i'm going give you the floor to tell people how hard it is in my lifetime, i have seen company after company fail you have something >> yes, we demonstrated hemophilia patients treatment. so this is our chief product here is a transformational treatment from the patient that's went through -- patients that were on care, two infusion every week to control their beating of their disease. while being on this care from 4.6 p per year to less than one. and they use it as a fusion went

down 98% so this is pretty dramatic results that obviously we are very excited about i think this is extremely good news for the hemophilia area >> so let's understand i'm used to having extraordinary rare drugs that have done so well for people. this has a large population. i know you're not veering from your strategy. there are a lot of people's lives that are going to be made very, very different because of biomarin on this >> yes that's correct worldwide, excluding india and china and the world that we can access they're around 150,000 patients with hemophilia 60% of them are severe this is the population we are addressing in italy. so this is going to have a significant impact on the

hemophilia community. >> what they've been using as i know from people who had it, they use a factor eight. you are 85% -- demonstrating much greater superiority to the current standard of care >> that's correct. and it's correct and by the way, this is the largest study ever done in history. 134 patients >> right i think the standard of care will change. by next year, if i'm right, everyone will go and buy this drug >> well, it may take longer than that but we're ready for it. we have manufacturing capacity for 10,000 treatments, patients. we're treating 10,000 patients per year we can increase from there if necessary. so we may be preparing for this and we're really excited >> in the meantime, you also had some terrific drugs, i know that's a broad name. but the expectation here's were

good you did better and that's going to continue to give you that diversified base of revenue growth. it's been so terrific. >> yes, that is also the number one cause of human dwarfism. the addressable population this will be a drug only for patients under age of 18 it's about 23, 24 patients in the developed world. we price that drug bat $250 thoi t -- $250,000 per year. we're the only approved product for this indication. and if we're going to be like this for many, many years to come >> look, i have to congratulate you. i know years ago you told me, look, we may have something for hemophilia and i know that it's been intractable, difficult and a horrible disease the it looks like you delivered more than i ever thought you

could. i'm going to congratulate you, j.j. chairman and ceo of biomarin for an amazing new drug that i hope gets approved worldwide. good to see you, sir. >> thanks, jim >> if you ever knew anyone that suffered from this disease, you know that there hasn't been anything good. he came here many years ago and told us this would happen. it's happening in 2022 and the stock is not reacting appropriately. it should be up more "mad money" is back after the break.

(judith) in this market, you'll find fisher investments is different than other money managers. (other money manager) different how? don't you just ride the wave? (judith) no - we actively manage client portfolios based on our forward-looking views of the market. (other money manager) but you still sell investments that generate high commissions, right? (judith) no, we don't sell commission products. we're a fiduciary, obligated to act in our client's best interest. (other money manager) so when do you make more money? only when your clients make more money? (judith) yep, we do better when our clients do better. at fisher investments we're clearly different.

your record label is taking off. but so is your sound engineer. you need to hire. i need indeed. indeed you do. indeed itant match instantly delivers quality candidates matching your job description. visit indeed.com/hire (inspiring music) - [narrator] at southern new hampshire university, matching your job description. you can reach your goals faster. that's because you can transfer in up to 90 credits towards your online degree. - i was able to cut my time in half. - [narrator] apply free at snhu.edu

(vo) verizon is going ultra! and so is manny! event planning with our best business unlimited plan ever! with 5g ultra wideband now in many more cities and up to 10 times the speed at no extra cost, witthe downloads are flyingin manfast!e cities and up to 10 verizon is going ultra, so your business can too.

he. it is time for "the lightning round. buy, buy, buy. sell, sell, sell easte and then the lightning round is over let's start with jim in texas. jim? >> caller: yeah. hey, jim thanks for all your help >> thank you >> i bought this stock late last year with "mad money." the idea was a more diversified top play the ticker is grwg grow generation >> we said if the stock was 40, drop it. you felt the bears and bulls and they get slaughtered time to go and frankly, we never looked back let's go to adam in indiana. adam >> caller: boo-yah from the hoosier state, jim >> nice to have you.

>> caller: i bought this stock last february when shipping -- container rates started to climb. stock is up over 100%. still pe under six and dividend yield over 20% the should i add my position ticker sblk? >> no. that's a bulk carrier. we don't likive in the bulk carriers, oil tankers. they are too inconsistent and too often led to heartache so we're not involved. let's go to suzanne in new york. suzanne? >> hello, jim. happy and healthy new year to you and your family. >> thank you, suzanne. same to you. what's up? >> caller: i'm calling about rvin we paid $104 right after the ipo. just wondering what your thoughts are >> hold on the coo just left. amazon has committed to the annual buy what they v but also wants to go away ford wants to sell its stock it can't do for a couple months. i don't think the setup is all

that great i'm sorry. thank you for the kind words mike in texas. mike >> caller: jim, greetings from houston. i sound a small cosmetic health care company 50% of the revenue is gapped to that income. share price down about half from the highs and pe ratio is in the low 30s. who are your thoughts of in mode i don't know why that stock fell so much. i think that's a great opportunity. i think one of those made with bad names. i think that's what i expect viewers to do is come up with makes it like in mode. i think that's a good call joanne >> yes hi, jim. thank you so much for taking my call >> all right, you're welcome >> caller: and for the wonderful advice you provide the financial education you give to so many with your show and investing club, anyway, my stock

is rio tinto i was looking for a good dividend payer with a low pe and decent earnings and also i had read that they had just bought a lithium mine in argentina. >> i always favored owning rio i think it's a great long term position i also like gold i think that this is a good mineral company over the multiple year time don't want to look over the short term you got a good one >> carrie in colorado. ka kay carrie. >> caller: boo-yah, jim. i'm so stoked to talk you to nothing. i'm an invest club member. i'm so grateful for you and everything you taught me i'm interested in investing possibly in novo cure. nvcr >> you know, i do not understand novocure got, you know, i happen to think that people just turn on companies that generally are in health care nobody seems to want anymore

they have a device that can be used for different areas against cancer it should be bought right here it's down a good deal. i would do some buying how about interest in maryland >> caller: how are you >> i'm doing well. how about you? >> caller: i'm doing all right i hope to get your nod on the ticker symbol lyci >> oh, man those are -- you know, i would love to just say yes i really would it's down a lot. but this lithium battery area is so controversial with so many players that i have to say wait a second it is too speculative for me period end of story hasan in georgia >> caller: mr. ycramer, thank yo for taking my call my question is what are your thoughts on at core incorporate? >> just plain perfect metal bending company that i like. other people may not like it

why? because it just too boring i think sometimes boring is good i like your choice let's go to jim in atlanta jim? >> caller: hey, jim. great to hear you, man love your show >> thank you >> caller: hey, i have a question for you virgin galactic. i rode the wave last year from $20 up to $1254. kind of washed it bounce all wait back down and i don't know where it is hovering now >> you know? i never liked it i saw it go up on a short squeeze. it's come back down a great deal maybe get a bounce but frankly, the stock is not for me and that, ladies and gentlemen, is the conclusion of the "lightning round"! >> "the lightning round" is sponsored by td ameritrade coming up, to which streaming platforms are you giving the time of day? cramer makes sense of the battle for your eyes and ears next.

♪♪ ♪♪ ♪♪

my poor baby, baby, baby, baby, i know the rolling stones weren't singing about the state of the at home entertainment business in 2022 when they wrote that song a long time ago. but it seems relevant today. i think last we might be out of time to watch more programming a few years ago when i asked the ceo of netflix about the biggest competition, he didn't talk about other streaming services or tv stations, he said time will be the real competition there won't be enough hours in the day to watch all programming you might like across all the programs and we were nowhere near that level. fast forward to today, from the looks of everyone in the industry, cable companies, video game players, streaming services, the meta verse, tv networks, we may have maxed out. we may have reached the level that we're out of time shocking even though we knew it

was coming take two announced take two purchase they make cheap mobile game sets that don't stack up to the beauty of "grand theft auto. mobile games are popular on the on the go consumers out sued the house and people multitasking like active igs is plays everywhere you go. mobile gaming expands the clock of the video game beyond what take two can deliver while you're at home then there is sports gamble. when you see the promotions the on line betting sites are offering, mil millions of people are watching the games on tv and watching them to the end to find out the final score. that translates to fewer hours for other types of entertainment. the whole industry needs to come to grip with this. i was looking at the must read news items, i was struck by a little fact, gallup just took a poll that showed that americans read 12.6 books a year that is the smallest number they measured since 1990. how much more can that go down

to free up more time to watch entertainment companies and their programming? can they really get more of your time i'm not sure we know that when the omicron strain is finished, we'll feel immunized. of and immunized person is less likely to spend time at home, less fearful that person is going to travel that means fewer hours for at home entertainment at home is the competition getting serious about grabbing their own slice of the clock case point, we downloaded this excellent program for the series looks like we have to watch something on paramount plus to get our money's worth. why not? now we are quarter cutters our bill is getting big. we don't want to get nothing spore something. i think we're at that inflection point. there just isn't enough time to consume even a fraction of the media you might want and it's not like we can create more time. now i'm sure we're in a situation where there still can

be excellent subviber growth internationally. i want to bet on the domestic bid anymore, not with this plethora of programming. some may be out of touch but just as definitely, we're all out of time. i like to say there is always a bull market somewhere, i promise to find it just for you here on "mad money." i'm jim cramer see you tomorrow the change the rules to ensure your right to vote and have it counted. i'm shepard smith. this is "the news" on cnbc president biden says he's tired of being quiet >> this is one of those defining moments in american history. >> taking on voting rights and the filibuster the changes he now supports and the strong words for those who don't. luring women with a dating app, then killing them and moving their remains around in a shopping cart. the investigation into a possible seria